Genome of the last living wild horse species mapped
On Jun. 13. 2024, University of Minnesota researchers announced they have successfully mapped the complete genome of the…
Agriculture | Artificial Intelligence | Biology | Biotechnology | CMO | CRO | Life Science News | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
BioMADE to Establish Bioindustrial Manufacturing Infrastructure in Minnesota
On Jun. 13, 2024, BioMADE announced an investment in a state-of-the-art bioindustrial manufacturing infrastructure in Minnesota, following support…
Avian Influenza A(H5N1) detected in dairy cattle in Minnesota
On Jun. 4, 2024, the Minnesota Department of Health reported that Avian Influenza A(H5N1) was detected in dairy…
Goat tested positive for same influenza virus affecting poultry in Stevens County, Minnesota
On Mar. 20, 2024, the Minnesota Board of Health announced that a Stevens County goat kid (juvenile goat)…
Nearly 1 million chickens killed on a Minnesota farm because of bird flu
On Nov. 6, 2023, the U.S. Department of Agricultureï¾’s (USDA) announced that nearly 1 million chickens on a…
‘Deaths of Despair’ contributed to 17% rise in Minnesota’s death rate during COVID-19 pandemic
On Mar. 13, 2023, Mayo Clinic published a study that showed the COVID-19 pandemic was linked to a…
Mayo Clinic received $100 million gift from Fred C. and Katherine B. Andersen Foundation to expand proton beam therapy services
On Oct. 10, 2022, the Mayo Clinic announced that The Fred C. and Katherine B. Andersen Foundation of…
USDA confirmed highly pathogenic Avian influenza in Minnesota
On Mar. 26, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service confirmed the presence…
FDA made low-risk determination for marketing of products from genome-edited beef cattle after safety review
On Mar. 7, 2022, the U.S. Food and Drug Administration announced it had made a low-risk determination for…
Monoclonal antibody treatment combo reduced hospitalization among high-risk patients with COVID-19
On Aug. 30, 2021, Mayo Clinic reported that in an observational study the combination of casirivimab and imdevimab…
Senolytics reduced COVID-19 symptoms in preclinical studies
On Jun. 8, 2021, Mayo Clinic researchers and colleagues at the University of Minnesota showed that COVID-19 exacerbates…
Mayo study found colon cancer driven by hereditary gene mutations in 1 in 6 patients
On Apr. 19, 2021, the Mayo Clinic announced a study that bolstered evidence that colorectal cancer is often…
Mayo Clinic launched new technology platform ventures to revolutionize diagnostic medicine
On Apr. 14, 2021, the Mayo Clinic announced a new technology platform initiative to deliver the next generation…
Cue Healthï¾’s connected point-of-care Covid-19 test demonstrated 97.8% agreement compared to Central Lab PCR Testing
On Feb. 11, 2021, Cue Health announced the results of an independent clinical validation study conducted by Mayo…
Cueï¾’s Molecular, point-of-care COVID-19 tests available under HHS and DoD pilot program
On Jan. 19, 2021, Cue Health announced that its molecular, point-of-care COVID-19 Tests were being distributed to five…
Mayo Clinic research confirmed critical role of masks in preventing COVID-19 infection
On Nov. 24, 2020, unpublished data from researchers at Mayo Clinic found that physical separation reduced the exposure…
Mayo Clinic reported 900 employees contracted COVID-19 from local community
On Nov. 17, 2020, the Mayo Clinic announced that more than 900 employees had contracted COVID-19 in the…
Agriculture | Artificial Intelligence | Biotechnology | CMO | CRO | Life Science News | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
U.S. Department of Defense approved $87 million for newest bioindustrial manufacturing innovation institute
On Oct. 20, 2020, the U.S. Department of Defense announced an $87 million, seven-year award to the BioIndustrial…
Lenzilumab COVID-19 case-control study published in Mayo Clinic Proceedings Journal
On Sept. 1, 2020, Humanigen announced the first case-control data of lenzilumab in severe COVID-19 demonstrated an 80%…
Mayo Clinic discontinued enrollment in Expanded Access Program for convalescent plasma with FDA Emergency Use Authorization
On Aug. 23, 2020, the Mayo Clinic announced that with the FDA Emergency Use Authorization of convalescent plasma,…
Failure to ﾑflatten the curveﾒ may kill more people than we thought
On Aug. 21, 2020, research by the University of Minnesota and the University of Washington found that every…
Mayo Clinic launched imaging solution to enable digital pathology across the enterprise
On Jun. 25, 2020, in support of Mayo Clinicï¾’s digital health and practice transformation initiatives, the Mayo Clinic…
Takeda received FDA approval to manufacture ENTYVIO (vedolizumab) drug substance at Brooklyn Park, Minnesota facility
On Jun. 23, 2020, Takeda Pharmaceutical announced that the FDA had approved the company’s submission for its biologics…
ViralClear opened enrollment with first patient dosing in phase II human trial of anti-viral MMPD oral solution for treatment of COVID-19
On Jun. 17, 2020, BioSig Technologies, and its subsidiary, ViralClear, announced that it had commenced patient enrollment with…
Thermo Fisher Scientific response to COVID-19 expanded to include new serology test
On May 13, 2020, Thermo Fisher Scientific announced it will expand its response to the COVID-19 pandemic by…
Mayo Clinic received $26 million from BARDA for COVID-19 convalescent plasma expanded access program
On May 4, 2020, Mayo Clinic was awarded a $26 million contract from the Biomedical Advanced Research and…
US Dept of Veterans Affairs participated in drug, plasma trials in fight against COVID-19
On May 1, 2020, the U.S. Dept. of Veterans Affairs (VA) announced participation in a series of clinical…
CHF Solutions shipped Aquadex product to COVID-19 specialty center in Minnesota
On May 1, 2020, CHF Solutions announced that it has shipped Aquadex product to a specialty care center…
ViralClear submits investigational New Drug Application to FDA for phase II clinical trials for merimepodib
On Apr. 24, 2020, BioSig Technologies announced that subsidiary ViralClear has submitted an Investigational New Drug (IND) application…
Mayo Clinic partnered with state of Minnesota, University of Minnesota on breakthrough COVID-19 initiative
On Apr. 23, 2020, the Mayo Clinic, Minnesota Department of Health and University of Minnesota announced a breakthrough…